Related Experiment Video

Updated: Aug 5, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Obstructive sleep apnoea presenting as failure to thrive in infancy

N J Freezer1, I K Bucens, C F Robertson

  • 1Department of Thoracic Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.

Journal of Paediatrics and Child Health
|June 1, 1995
PubMed

Insights

Adenotonsillectomy effectively treats obstructive sleep apnoea (OSA) in infants, significantly improving weight gain velocity in those with failure to thrive (FTT). Linear growth was not significantly affected by the procedure.

Area of Science:

  • Pediatric Otolaryngology
  • Pediatric Sleep Medicine
  • Pediatric Surgery

Background:

  • Obstructive sleep apnoea (OSA) is a significant concern in infants.
  • Failure to thrive (FTT) can be associated with OSA in this age group.
  • Adenotonsillectomy is a common surgical intervention for upper airway obstruction.

Purpose of the Study:

  • To evaluate the postoperative outcomes of adenotonsillectomy in infants under 18 months.
  • To assess the impact on weight gain and linear growth.
  • To determine the resolution rate of OSA symptoms.

Main Methods:

  • Retrospective study of infants undergoing adenotonsillectomy over a 5-year period.
  • Data collected via medical records review and parental telephone interviews.
  • Analysis of pre- and postoperative weight gain and linear growth velocities.

Main Results:

  • Adenotonsillectomy resolved OSA symptoms in 79% of infants.
  • Infants with preoperative FTT showed a significant increase in weight gain velocity post-surgery (P < 0.001).
  • No significant change in linear growth velocity was observed.

Conclusions:

  • OSA should be considered in infants with FTT.
  • Adenotonsillectomy is an effective treatment for infantile OSA, potentially improving weight gain.
  • Further physiological studies may be needed for equivocal OSA cases.
Abstract

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Laryngeal Mask Airway (LMA) Placement in a Neonatal Patient Simulator Using a Non-Inflatable Supraglottic Airway (SGA)04:56

Laryngeal Mask Airway (LMA) Placement in a Neonatal Patient Simulator Using a Non-Inflatable Supraglottic Airway (SGA)

Published on: July 14, 2023

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...